Table 2.
Parameters | Bacteria | Yeasts | Insect cells | Mammalian cells | Plants |
---|---|---|---|---|---|
VLP yield | Up to 250 mg/L culture (Mohsen et al., 2022) | Up to 270 mg/L culture (Yang et al., 2020) | Up to 171 mg/L culture (Lin et al., 2015) | Up to 33.7 mg/L culture (Hirschberg et al., 2023) | Up to 200 μg/g fresh leaf tissue (Mardanova et al., 2022) |
Growth period prior to VLP production | < 1 day (Sazegari et al., 2023; Yong et al., 2015) | ∼1 to 2 days (Sanchooli et al., 2020; Wetzel et al., 2019) | ∼2 to 3 days | ∼2 to 3 days | 28 days to 42 days (D'Aoust et al., 2008; Rutkowska et al., 2019) |
VLP production period | 5 h – 18 h (Sazegari et al., 2023; Yong et al., 2015) |
66 h – 96 h (Sanchooli et al., 2020; Wetzel et al., 2019) | 72 h – 144 h (Tretyakova et al., 2013; Xu et al., 2019) | 48 h - 144 h (Buffin et al., 2019; Xu et al., 2020) | 96 h - 192 h (Mardanova et al., 2022; Rutkowska et al., 2019) |
VLP complexity | Simple | Simple | Complex | Complex | Complex |
Antigen displaying strategy | Genetic fusion, protein conjugation | Genetic fusion, protein conjugation | Genetic fusion, co-expression with viral protein monomers, protein conjugation | Genetic fusion, co-expression with viral protein monomers, protein conjugation | Genetic fusion, protein conjugation |
Post-translational modification (PTM) pattern | Lacks PTM | High mannosylation (causes adverse immune reaction and reduces serum half-life) (Khan et al., 2017; Wildt and Gerngross, 2005) | Paucimannosylation and lacks terminal sialylation (reduces serum half-life) (Khan et al., 2017; Tomiya et al., 2004) | Highly resembles human cells (Khan et al., 2017) | Contains xylose and fucose residues (potential allergen), lacks terminal sialylation (Khan et al., 2017; Mercx et al., 2017) |
Scalability | Easy | Easy | Difficult | Difficult | Easy |
Production cost | Low | Low | High | High | Low |